American Kidney Fund Pushes Congress for Living Donor Protections
Event summary
- American Kidney Fund (AKF) convened a Congressional briefing on July 21, 2026 to advocate for the bipartisan Living Donor Protection Act (H.R. 4583/S.1552).
- The bill aims to codify job and insurance protections for living organ donors, addressing a critical gap in the system.
- Over 97,000 Americans are waiting for a kidney transplant, with 11 dying daily due to wait times.
- AKF has been advocating for living donor protections since 2021 through its annual State of the States report.
The big picture
The push for the Living Donor Protection Act reflects growing recognition of systemic barriers in organ donation. With nearly 90% of transplant waitlists dominated by kidney patients, legislative action could significantly impact a critical healthcare bottleneck. AKF's advocacy highlights the intersection of policy, insurance regulations, and public health outcomes.
What we're watching
- Legislative Momentum
- Whether the bipartisan support for the Living Donor Protection Act can overcome previous legislative hurdles and secure passage.
- Insurance Industry Response
- How insurers will adapt to potential new regulations prohibiting coverage limitations for living donors.
- Organ Donation Rates
- The pace at which increased protections could boost living donor transplants and reduce waitlist mortality.